Clinical Trial

Liposomal vs Conventional Oral Iron After Sleeve Gastrectomy

Study acronym: anemia
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 13, 2026 (before its estimated July 25, 2026 completion). Its status may not reflect the trial's current state.
Summary
Low-dose liposomal iron (17-34 mg elemental/day) was compared with standard conventional oral iron (100-200mg elemental/day) in the treatment of iron deficiency anemia following sleeve gastrectomy. Liposomal iron provided superior hematological improvement and gastrointestinal tolerance.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-05-31 -> 2026-07-25 2026-06-17
minor Completion moved earlier: 2026-12-31 -> 2026-07-30 2026-06-17
Trial Details
NCT Number NCT07366502
Lead Sponsor Medeni Şermet
Conditions İron Deficiency Anemia, Liposomal Iron Replacement, Conventional Iron Replacement
Enrollment 70 participants
Start Date 2025-09-01
Primary Completion 2026-07-25 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-13